Amgen Manufacturing Limited (AML) (Prefilled syringe: drug substance manufacturing, primary packaging, quality control testing; Prefilled pen: drug substance manufacturing, primary packaging, quality control testing)
UkraineAll drugs from this manufacturer
-
The drug is intended as add-on maintenance therapy for adults and children aged 12 years and older with severe asthma that is not adequately controlled despite the use of high-dose inhaled corticosteroids in combination with other maintenance treatments.
Dosage form: solution for injection
Active substance Dosage tezepelumab 210 mg/1.91 ml (110 mg/ml) ATC: R03DX11